Domenico Maddaloni

Domenico Maddaloni serves as a key procurement lead within W40M MRCO Europe under the Department of the Army, responsible for acquiring critical medical diagnostic equipment, in-vitro diagnostic reagents, and clinical laboratory services essential to battlefield and garrison healthcare readiness. His work directly supports the Army’s combat medicine mission by ensuring timely access to high-precision medical devices and analytical systems that enable rapid, accurate patient diagnostics in austere environments. He manages full lifecycle contracts for complex medical technologies, including clinical analyzers, point-of-care testing platforms, and associated calibration and maintenance services, often requiring stringent regulatory compliance and technical validation. Maddaloni maintains consistent, long-term relationships with specialized medical suppliers, including Roche Diagnostics S.p.A., Meditrade Medical Trading GmbH, and Colser Società Cooperativa. These partnerships reflect a preference for established manufacturers and distributors with proven capabilities in supplying FDA- and CE-certified diagnostic systems, reagent kits, and service support infrastructure. His contracting approach prioritizes technical reliability, supply chain resilience, and compliance with military medical standards, often leveraging blanket purchase agreements and indefinite-delivery/indefinite-quantity (IDIQ) vehicles to sustain operational continuity. His procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a mission-critical focus on technical performance and rapid deployment over socioeconomic preferences, aligning with the urgency of sustaining frontline medical capabilities. While small business participation is not formally prioritized, vendors must still meet rigorous qualification and quality assurance benchmarks. Maddaloni’s primary focus lies in NAICS 621340, reflecting extensive procurement of clinical laboratory and diagnostic service contracts, complemented by significant activity in NAICS 325413 for in-vitro diagnostic substance manufacturing. His expertise centers on procuring advanced immunoassay systems, hematology analyzers, and molecular diagnostic platforms, demonstrating deep technical fluency in medical laboratory automation and diagnostic innovation.